Antimicrobial Resistance Profiles of Pseudomonas aeruginosa in the Arabian Gulf Region Over a 12-Year Period (2010–2021)
Journal of Epidemiology and Global Health · 2024
DOI: 10.1007/s44197-024-00191-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Epidemiology and Global Health, 2024. Verfasst von A Alatoom und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Laboratory, Abu Dhabi, UAE. aalatoom@ssmc.ae. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Anti-Bacterial Agents. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: pfizer gulf fz llc.
Abstract (Originalsprache)
Objectives
To evaluate literature from a 12-year period (2010–2021) on the antimicrobial resistance profile of Pseudomonas aeruginosa from the Arabian Gulf countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates).
Methods
An electronic literature search was conducted for articles on antimicrobial resistance in P. aeruginosa and associated phenotypes, covering the period of 1st January 2010 to 1st December 2021.
Results
Antimicrobial resistance in the Arabian Gulf was highest to meropenem (10.3–45.7%) and lowest to colistin (0.0–0.8%), among the agents tested. Annual data showed that ceftazidime resistance (Kuwait), piperacillin-tazobactam non-susceptibility (Qatar), and aztreonam, imipenem, and meropenem resistance (Saudi Arabia) increased by 12–17%. Multiple mechanisms of carbapenem resistance were identified and multiple clones were detected, including high-risk clones such as ST235. The most common carbapenemases detected were the VIM-type metallo-β-lactamases.
Conclusions
Among P. aeruginosa in the Arabian Gulf countries, resistance to meropenem was higher than to the other agents tested, and meropenem resistance increased in Saudi Arabia during the study period. Resistance to colistin, a classic antibiotic used to treat Pseudomonas spp. infections, remained low. The VIM-type β-lactamase genes were dominant. We recommend local and regional antimicrobial resistance surveillance programs to detect the emergence of resistance genes and to monitor antimicrobial resistance trends in P. aeruginosa .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Reference Laboratory, Abu Dhabi, UAE. aalatoom@ssmc.ae.
- Department of Pathology and Laboratory Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, UAE. aalatoom@ssmc.ae.
- King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
- Alfaisal University, Riyadh, Saudi Arabia.
- College of Natural and Health Sciences, Zayed University, Dubai, UAE.
- Pfizer, Jeddah, Saudi Arabia.
Förderung
- pfizer gulf fz llc
Zitieren
APA
Alatoom, A., Alattas, M., Alraddadi, B., Moubareck, C. A., Hassanien, A., Jamal, W., Kurdi, A., Mohamed, N., Senok, A., Somily, A. M., & Ziglam, H. (2024). Antimicrobial Resistance Profiles of Pseudomonas aeruginosa in the Arabian Gulf Region Over a 12-Year Period (2010–2021). Journal of Epidemiology and Global Health. https://doi.org/10.1007/s44197-024-00191-y
Vancouver
Alatoom A, Alattas M, Alraddadi B, Moubareck CA, Hassanien A, Jamal W, et al. Antimicrobial Resistance Profiles of Pseudomonas aeruginosa in the Arabian Gulf Region Over a 12-Year Period (2010–2021). Journal of Epidemiology and Global Health. 2024. doi:10.1007/s44197-024-00191-y
BibTeX
@article{Alatoom2024,
author = {Alatoom, A and Alattas, M and Alraddadi, B and Moubareck, C Ayoub and Hassanien, A and Jamal, W and Kurdi, A and Mohamed, N and Senok, A and Somily, A M and Ziglam, H},
title = {Antimicrobial Resistance Profiles of Pseudomonas aeruginosa in the Arabian Gulf Region Over a 12-Year Period (2010–2021)},
journal = {Journal of Epidemiology and Global Health},
year = {2024},
doi = {10.1007/s44197-024-00191-y}
}
EUVIMED